KevinCompounds said:The useful move here is to separate what is established from what is widely repeated.
KevinCompounds has the substance of this right. The condition it depends on is worth stating. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.
MikeNYC_runner said:I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
This answered a question I did not know how to ask. I will report back once I have actually tried it.
KevinCompounds said:The useful move here is to separate what is established from what is widely repeated.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOne concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.